COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
- PMID: 34342659
- PMCID: PMC8329628
- DOI: 10.1007/s00134-021-06499-8
COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
Conflict of interest statement
SN: MSD, Gilead, Pfizer, Biomérieux, Mio Rad, Fischer and Paykel (lecture). Other authors: none.
Comment in
-
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges.Intensive Care Med. 2021 Nov;47(11):1339-1340. doi: 10.1007/s00134-021-06510-2. Epub 2021 Sep 1. Intensive Care Med. 2021. PMID: 34468820 Free PMC article. No abstract available.
Comment on
-
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry.Intensive Care Med. 2021 Oct;47(10):1158-1160. doi: 10.1007/s00134-021-06471-6. Epub 2021 Jul 16. Intensive Care Med. 2021. PMID: 34269853 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
